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Abstract 
Background: Infection and sepsis represent major 
problems for Intensive Care Units (ICU) patients. It is 
important to identify factors that may give early clues as 
to the adequateness of empiric antibiotic therapy in septic 5 
patients so that an “early rescue” strategy can be 
implemented. We tried to correlate the timing of 
administration of appropriate antibiotics with the evolution 
of early organ dysfunction and daily C-reactive protein 
(CRP) measurements. 10 
Methods: A retrospective review of 58 adult ICU patients 
with bacteraemia was performed. Bacteraemia was 
defined according to Centers for Disease Control and 
Prevention criteria.  
The primary combined outcome was ICU/hospital 15 
mortality and secondary outcomes were infection 
resolution, SOFA evolution (day0-day3) and the pattern 
of CRP response. 
Results: ICU mortality in patients with inappropriate initial 
ATB was more than double of patients with appropriate 20 
ATB (p = 0.044). At 48h of antibiotic effect, patients with 
appropriate therapy had 10.0% mean decrease in CRP, 
while it continued to rise in those with inappropriate 
therapy (p<0.001). 
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Results were similar for patients with adequate therapy 
having a smaller increase in CRP value in the first 24h 
under antimicrobial treatment (p=0.218), but a significant 
bigger decrease by the second day (p=0.025). 
Conclusions: We found a strong relationship between 5 
ATB appropriateness and ICU mortality (p=0.044). 
Differences in CRP variation between groups become 
evident early in the course of events and may be helpful 
when deciding on the need to change antibiotics. 
Key Words: Sepsis, Bacteraemia, ICU, Anti-Infective 10 
Agents, Timing  
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Introduction 
Infection and sepsis represent major problems for 
patients admitted to intensive care units (ICU). 
Whether as the cause for ICU admission [1] or as an ICU-
acquired [2,3] event, it is associated with a significant risk 5 
of death and prolonged hospital stay. Patients who 
develop acute organ dysfunction in this setting (severe 
sepsis) are at particular risk [4] mainly those with severe 
hemodynamic failure (septic shock). In these latter 
patients, mortality is reported to be greater than 50% [3,5-10 
8]. 
Optimal therapy for these patients is based on three 
fundamental principles, namely appropriate antibiotic 
therapy (ATB) (i.e., agents active against the causative 
microorganism), source control and support of failing 15 
organs [9]. Of these, the appropriateness of antibiotic 
therapy is likely to be the intervention with the most 
impact on prognosis, particularly in more severe patients 
[8,10] if adequate organ support is supplied.  
Also, there is evidence that failure to promptly initiate 20 
appropriate therapy has as much adverse consequences 
on outcome as a wrong choice of the antibiotic [11]. 
Several studies have shown a link between late 
administration of appropriate antibiotics and poor 
outcomes in many different settings [12,13].  25 
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This gave rise to the concept of antibiotic adequateness 
which widens the one of appropriateness by taking in 
consideration the timing of administration, use of 
adequate doses and dosing regimens and utilisation of 
agents with adequate penetration into the focus of 5 
infection [9].  
 As such it is important to identify factors that may give 
early clues as to the adequateness of empiric antibiotic 
therapy in septic patients so that an “early rescue” 
strategy can be implemented. This would entail clinical 10 
reevaluation, looking for unsuspected foci or collections 
amenable to source control measures, and eventually 
early escalation of the antibiotic spectrum, for example in 
the case of worsening organ failure.  
One of the variables to consider in this setting is the 15 
evolution of organ dysfunction/failure. Several tools are 
available that allow quantification of organ failure (OF) 
[14-16] and the variation of OF with time has been shown 
to correlate well with prognosis in ICU patients [16,17].  
Patterns of C - reactive protein (CRP) evolution have also 20 
been shown to be of use in predicting response to 
antibiotics [18,19].  
We tried to correlate the timing of administration of 
appropriate antibiotics with the evolution of early organ 
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dysfunction and daily CRP measurements in patients with 
bacteraemia.   
 
Materials and Methods 
A retrospective cohort analysis of adult ICU patients 5 
between 1st January and 30th June 2010 was performed 
in two general ICUs, at Hospital de São João, a teaching 
hospital in Oporto, Portugal. 
Patients were included if they were ≥18 years old and 
had primary or secondary acquired bloodstream infection 10 
(BSI) according to the Centers for Disease Control and 
Prevention criteria (CDC) [20]. An exception to this was 
catheter related BSI where a less stringent criterion was 
used. In these cases the source was considered to be the 
central line if CDC criteria for diagnosis were met or if 15 
there was no other apparent foci of infection and the 
opinion of the attending physicians, based on review of 
the clinical records, was that the catheter was the likely 
source of infection. It must be noted that formal 
microbiological documentation (i.e., CVC and peripheral 20 
cultures plus catheter tip) was lacking in most of these 
cases.  If a patient had more than one episode of BSI 
during a hospitalization, only the first episode was 
considered. 
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The following data were obtained by trained medical 
abstractors from each patient’s medical records: age, 
gender, comorbidities, ICU and hospital length of stay, 
reason for ICU admission, presence or absence of 
infection upon admission to the ICU, place of infection 5 
acquisition (community, nosocomial or ICU) and primary 
focus of infection. Simplified Acute Physiology Score 
(SAPS II) severity score at ICU admission and Sepsis-
related Organ Failure Assessment score (SOFA) at days 
0, 1 and 3 were also calculated. Central Nervous System 10 
(CNS) SOFA was not valorized because of great number 
of sedated patients. 
Also the following comorbid conditions were recorded: 
diabetes, chronic heart failure (≥ II class of New York 
Heart Association), cerebral vascular disease, other 15 
significant neurological diseases (ex: lateral sclerosis, 
epilepsy), chronic renal disease (requiring dialysis or 
glomerular filtration rate:GFR<60ml/min/1.73m2), chronic 
lung disease (requiring home oxygen therapy or 
ventilation), chronic hepatic disease (cirrhosis histological 20 
confirmation or clinical diagnosis of portal hypertension), 
immunosuppression (including prednisolone treatment 
>30mg/day for more than 3 months/cancer chemotherapy 
or immunomodulating agents in the last 30 days) and 
active neoplasms. 25 
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Both ICUs have standing protocols regarding adequate 
drawing and handling of blood and tip cultures. 
Specifically catheter tips are only cultured if there is a 
clinical suspicion of catheter associated infection. Routine 
drawing of blood cultures is not local ICU practice. We 5 
thus regarded all positive blood cultures obtained as 
indicative of suspected infection. In accord to CDC 
guidelines, we did not include cultures of coagulase-
negative staphylococci or other common commensal skin 
organisms unless two cultures separately isolated the 10 
same species of microorganism. Data from intravascular 
device tip culture wasn’t always available, so most of the 
catheter related BSIs (CRBSI) were only clinically defined 
and rarely documented according the accepted CDC 
criteria for CRBSI. 15 
Hospital microbiology records of positive blood cultures 
were gathered. Date, time and susceptibility profiles for 
all positive blood cultures were obtained.  
All antimicrobials administered were noted, including the 
date, time, dose, route, and duration. Antibiotic 20 
appropriateness was determined according to 
microbiological susceptibility and adequacy was defined 
as appropriateness plus timely (< 3 hours) antibiotic 
administration. 
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For the purpose of calculating time (in minutes) elapsed 
until administration of antibiotics, zero time (t0) was 
considered the time of registration of the blood cultures in 
the central laboratory and day zero (day0) was the day of 
first positive bloodstream. Time of antibiotic 5 
administration was abstracted from nursing charts. 
Whenever registration of blood cultures was latter than 
the hour of the administration of antibiotics we considered 
therapy to have been given immediately after the drawing 
of blood cultures. 10 
The primary combined outcome was ICU/hospital 
mortality and secondary outcomes were infection 
resolution (as documented in the clinical records), organ 
dysfunction improvement (defined by a decrease in global 
SOFA score ≥ 2 from day zero to day one/day zero to day 15 
three or a positive variation in delta SOFA day1-3 on “per 
organ” SOFA) and the pattern of CRP response to 
antibiotherapy, defined as the CRP rate of decline from 
day1 to day2, day3 and day5.  
Data were screened in detail for missing information, 20 
implausible and outlying values. 
Continuous variables were expressed as means and 
standard deviations (SD) or median and interquartile 
range (IQR) if the distribution was clearly asymmetric. 
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Comparisons between groups were performed with two-
tailed unpaired Student’s t test or Mann-Whitney U test 
for continuous variables according to data distribution. 
Fisher’s exact test and Chi-square test was used to carry 
out comparisons between categorical variables as 5 
appropriate. All statistics were two-tailed and significance 
level was set at 0.05. Data were analyzed using PASW 
v.18.0 for PC (SPSS, Chicago, IL).  
Since this observational study did not require any 
deviation from routine medical practice, the Health Ethics 10 
Committee of the Hospital São João approved the study 
design and waived the need of informed consent. 
 
Results 
We analyzed a total of 58 patients with a first episode of 15 
bacteraemia. 
Mean age was 62 years. 62% were male (see Table 1). 
Median ICU and in-hospital length of stay was 16 days 
and 38 days, respectively. During the same period global 
ICU length of stay was 13 days.  20 
Most of the patients (91.2%) had severe sepsis, half of 
them (53.4%) with septic shock, on day0.  
70.7% of the bloodstream infections were hospital 
acquired (Table2), 51.7% in the ICU.  
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Clinically documented resolution of infection occurred in 
64% of patients (37/54 patients). 
ICU and hospital mortality were 37.9% and 53.4%, 
respectively.  
Half of the bloodstream infections (49.8%) were due to 5 
Gram negative bacilli (GNB). Gram positives accounted 
for 37.9 % and Candida spp was recovered in 12% of 
patients. Most of the bloodstream infections were 
catheter related (22.4%), with intra-abdominal (19%) and 
respiratory (15.5%) foci being the second and third most 10 
common. 10% of infections had an unknown focus.  
When relating microorganisms (MO) and focus of 
infection (Table 3), GNB bacteraemias were more 
commonly associated with respiratory and intra-
abdominal foci, while gram positives were predominantly 15 
related with catheter infections. Fungaemia was mainly 
seen in Intra-abdominal infection. 
 
With regard to antibiotic appropriateness (i.e., using an 
antibiotic active against the causative microorganism) we 20 
found no differences in the mean age of patients, gender, 
and severity (severe sepsis or septic shock), or place of 
acquisition, of infection.  
ICU mortality in patients with inappropriate initial ATB 
was more than double that of patients with appropriate 25 
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ATB, differences that were statistically significant (p = 
0.044), see Table 1. When analyzing hospital death, 
patients with inappropriate ATB had a higher mortality 
than patients with initially appropriate ATB (76.9% vs 
42.5%) although not statistically significant (p = 0.054).  5 
Most (80.6%) of patients with appropriate ATB had 
infection resolution against 38.5% in the inappropriate 
group (p=0.01).  
Regarding the CRP variation with antibiotic 
appropriateness, patients with appropriate antibiotics had 10 
a significantly greater decrease comparing with the 
inappropriate group. In the first 24h under the antibiotic 
effect (day one to day two), those with appropriate 
therapy had a median smaller increase (2.4%) in the CRP 
comparing with those with inappropriate therapy (39.9%; 15 
p=0.03). At 48h post-antibiotic, patients with appropriate 
therapy had 10.0% mean decrease in CRP, while it 
continued to rise in those with inappropriate therapy 
(26.7%; p<0,001). At the fourth day of antimicrobial 
therapy, the CRP value decreased almost to half in the 20 
appropriate group (48.1%) and only 8.5% in the 
inappropriate group (p=0.002) (see Figure 1).  
 
Antibiotic adequacy. When comparing the characteristics 
of the two groups (adequate/inadequate), there were 25 
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significant differences (p = 0.001) with respect to the 
origin of the bacteraemia. Most cases of bacteraemia in 
patients with adequate (i.e., appropriate and early) ATB 
came from the community (68.8%), while infections in 
patients with inadequate therapy were mostly nosocomial 5 
(82.4%). There were no significant differences between 
groups regarding mean age, gender, comorbidities and 
severity of infection on admission (SAPS II, presence / 
absence of septic shock). Although, patients with 
adequate ATB had a mean SAPS II score higher than 10 
those with inadequate (p=0.09) 
The proportion of patients with septic shock was 68.6% in 
the group of adequate therapy and 44.1% in patients 
receiving inadequate antimicrobials. 
Both ICU (43.8% vs 35.3%) and hospital (56.3% vs 15 
52.9%) mortality was higher in patients with adequate 
ATB than on those with inadequate ATB, although these 
differences were not significant (p = 0.75 and p = 1.0 
respectively). The same happened when looking at the 
resolution of the infection. Patients with adequate ATB 20 
achieved a higher rate of infection resolution (66.7% vs 
65.6%), again not statistically significant (p = 1.0). 
Regarding the relationship of antibiotic adequacy and 
CRP evolution the results were as follows: patients with 
adequate therapy had a non-significant smaller increase 25 
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in CRP value in the first 24h under antimicrobial 
treatment (2.3% vs 7.7%; p=0.218), but a significant 
larger decrease by the second (19% decrease vs 1.1% 
increase; p=0.025) and fourth day (53% decrease vs 38% 
decrease; p=0.04) of therapy.  5 
 
Evolution of organ failure. Global Organ dysfunction 
worsened in 70% of patients with a median increase in 
SOFA score of 2 points between days 0 and 3. We found 
no significant differences in total SOFA score variation 10 
when looking at both appropriateness and adequacy. 
The evolution of “per organ” SOFA on days 0, 1 and 3 in 
relation with appropriateness is presented on Table 4. 
Patients with adequate antimicrobials had a significant 
higher median lactate level at day zero (2.1 vs 1.5 15 
mmol/L; p=0.01). Differences in median lactate levels 
between appropriate and inappropriate groups from day 
zero to day three were non-significant. 
 
Timing of ATB. With regard to the timing of antibiotic 20 
administration we found that patients with nosocomial 
infection were significantly more likely to receive delayed 
antibiotic therapy when compared with patients with 
community acquired sepsis (78.1% vs 25%; p=0,001). 
We also found that the presence of septic shock was 25 
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associated with earlier administration of antibiotics (56% 
of patients under 3 hrs vs 21.7% in no shock; p=0.02).  
 
Discussion  
The diagnosis of infection in ICU patients can be 5 
challenging. Therefore, we decided to limit this analysis to 
patients with bacteraemia in order to include only patients 
with an undisputed diagnosis of infection.  
Bacteraemia in ICU patients is a frequent event and is 
associated with elevated mortality (during the study 10 
period global ICU mortality in both participating units was 
28.6%) and longer ICU stays. 
The main finding of this study is the striking relationship 
between antibiotic inappropriateness and mortality. Even 
with a small sample size it was possible to demonstrate a 15 
significant increase in ICU mortality (61.5%) in patients 
who received initially inappropriate antibiotics against 
27.5% in the appropriate ATB group (p=0.044). This 
clearly underscores the need to thoroughly access the 
patient with severe infection upon admission in order to 20 
make the best possible decision regarding empiric 
antibiotics. In fact a number of previous studies have 
described this association in different settings [8,10,11].  
The results found when combining appropriateness and 
timing (i.e., adequacy) were confounding. The higher 25 
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mortality (56.3% vs 52.9%; p=1.0) in the group that 
received early (<3h), appropriate antibiotics, although 
statistically insignificant is, nevertheless, bewildering. It 
must be noted that the proportion of patients in this group 
who developed septic shock was greater than in the rest 5 
of the study sample and that this may have biased this 
result as the expected mortality resulting from septic 
shock is extremely high [3,6,7]. 
With regard to delays in antibiotic administration we found 
that patients with hospital acquired infection are at a 10 
greater risk of receiving delayed therapy when compared 
with those admitted through the Emergency Department 
(ED). Our hospital has an ED based rapid response 
system for sepsis instituted since 2008 and this may 
account for some of this difference. These kind of 15 
systems have been associated with improved process of 
care (including diminished time to antibiotic 
administration) in a number of different settings [21,22], 
and a recent meta-analysis confirmed this finding [23].  
Another issue that may be relevant is the difficulty 20 
associated with identifying sepsis. This has been 
recognized as a major barrier to implementation of 
bundled care in American EDs [24] and one must admit 
that it may be an even larger problem in ward acquired 
infection.  25 
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The analysis of SOFA score variation showed that, 
although global SOFA seems to be of little use in the 
earlier stages of disease some of its components may 
have some value when trying to decide, on the basis of 
limited data, whether therapy was appropriate - namely 5 
CV and respiratory SOFA may be reasonable indicators 
of improvement. Probably due to the small sample size, 
we were unable to find any statistically significant 
differences. 
As for CRP variation we found significant differences that 10 
become evident as soon as 24h after administration of 
appropriate antibiotics (assuming that most of patients 
were already doing antibiotics), suggesting this may be a 
good indicator for “early rescue” strategies. The early 
variation of CRP has been also associated with antibiotic 15 
adequacy [25] and outcomes [18]  
Our study has several important limitations. The first is its 
retrospective design that impairs adequate data gathering 
and limits the strenght of our conclusions. Second is the 
small sample size, again limiting the statystical power of 20 
the study. 
 
In conclusion, we found a strong relationship between 
ATB appropriateness and mortality in concordance with 
findings previously reported by other groups. Patients 25 
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Learning Points 
-Bacteraemia in ICU patients is frequently associated 
with poor outcomes 
-Inappropriate therapy is significantly related to 
increased mortality 
-Patients with hospital-acquired infection may be at 
increased risk of delayed therapy 
-Early CRP and OF variations may be suggestive of 
appropriateness  
with hospital-acquired infection may be at greater risk of 
receiving delayed therapy. 
The lack of association between antibiotic adequacy and 
outcomes was unexpected but may be related to the 
small sample size and to the greater proportion of 5 
patients with septic shock in this group. 
Differences in CRP variation between groups become 
evident early in the course of events and may be helpful 
when deciding on the need to change antibiotics. 
 10 
 
 
Acknowledgements 
The author intend to acknowledge the collaboration of Dr 
Rodrigo Pimentel, Dr Marta Couto, Professor Ana 15 
Azevedo, Professor José Artur Paiva and the medical 
team of the Intensive Care Unit of the Emergency 
Department from Hospital São João (UCIPU). 
19 
 
 
 
 
References: 
[1] Cardoso T, Carneiro AH, Ribeiro O, Teixeira-Pinto 
A, Costa-Pereira A. Reducing mortality in severe sepsis 
with the implementation of a core 6-hour bundle: results 
from the Portuguese community-acquired sepsis study 5 
(SACiUCI study). Crit Care, 2010;14:R83. 
[2] Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, 
Martin CD, et al. International study of the prevalence and 
outcomes of infection in intensive care units. JAMA : the 
journal of the American Medical Association, 10 
2009;302:2323-9. 
[3] Vincent JL, Sakr Y, Sprung CL, Ranieri VM, 
Reinhart K, Gerlach H, et al. Sepsis in European 
intensive care units: results of the SOAP study. Critical 
care medicine, 2006;34:344-53. 15 
[4] Rangel-Frausto MS, Pittet D, Costigan M, Hwang 
T, Davis CS, Wenzel RP. The natural history of the 
systemic inflammatory response syndrome (SIRS). A 
prospective study. JAMA : the journal of the American 
Medical Association, 1995;273:117-23. 20 
[5] Annane D, Aegerter P, Jars-Guincestre MC, 
Guidet B. Current epidemiology of septic shock: the CUB-
Rea Network. American journal of respiratory and critical 
care medicine, 2003;168:165-72. 
20 
 
 
 
 
[6] Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, 
Gerlach H, Grond S, et al. Epidemiology of sepsis in 
Germany: results from a national prospective multicenter 
study. Intensive care medicine, 2007;33:606-18. 
[7] Povoa PR, Carneiro AH, Ribeiro OS, Pereira AC. 5 
Influence of vasopressor agent in septic shock mortality. 
Results from the Portuguese Community-Acquired Sepsis 
Study (SACiUCI study). Critical care medicine, 
2009;37:410-6. 
[8] Kumar A, Ellis P, Arabi Y, Roberts D, Light B, 10 
Parrillo JE, et al. Initiation of inappropriate antimicrobial 
therapy results in a fivefold reduction of survival in human 
septic shock. Chest, 2009;136:1237-48. 
[9] Dellinger RP, Levy MM, Carlet JM, Bion J, Parker 
MM, Jaeschke R, et al. Surviving Sepsis Campaign: 15 
international guidelines for management of severe sepsis 
and septic shock: 2008. Critical care medicine, 
2008;36:296-327. 
[10] Valles J, Rello J, Ochagavia A, Garnacho J, Alcala 
MA. Community-acquired bloodstream infection in 20 
critically ill adult patients: impact of shock and 
inappropriate antibiotic therapy on survival. Chest, 
2003;123:1615-24. 
[11] Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef 
MH. The influence of inadequate antimicrobial treatment 25 
21 
 
 
 
 
of bloodstream infections on patient outcomes in the ICU 
setting. Chest, 2000;118:146-55. 
[12] Kumar A, Roberts D, Wood KE, Light B, Parrillo 
JE, Sharma S, et al. Duration of hypotension before 
initiation of effective antimicrobial therapy is the critical 5 
determinant of survival in human septic shock. Critical 
care medicine, 2006;34:1589-96. 
[13] Proulx N, Frechette D, Toye B, Chan J, Kravcik S. 
Delays in the administration of antibiotics are associated 
with mortality from adult acute bacterial meningitis. QJM : 10 
monthly journal of the Association of Physicians, 
2005;98:291-8. 
[14] Vincent JL, Moreno R, Takala J, Willatts S, De 
Mendonca A, Bruining H, et al. The SOFA (Sepsis-related 
Organ Failure Assessment) score to describe organ 15 
dysfunction/failure. On behalf of the Working Group on 
Sepsis-Related Problems of the European Society of 
Intensive Care Medicine. Intensive care medicine, 
1996;22:707-10. 
[15] Marshall JC, Cook DJ, Christou NV, Bernard GR, 20 
Sprung CL, Sibbald WJ. Multiple organ dysfunction score: 
a reliable descriptor of a complex clinical outcome. 
Critical care medicine, 1995;23:1638-52. 
[16] Jones AE, Trzeciak S, Kline JA. The Sequential 
Organ Failure Assessment score for predicting outcome 25 
22 
 
 
 
 
in patients with severe sepsis and evidence of 
hypoperfusion at the time of emergency department 
presentation. Critical care medicine, 2009;37:1649-54. 
[17] Routsi C, Pratikaki M, Sotiropoulou C, Platsouka 
E, Markaki V, Paniara O, et al. Application of the 5 
sequential organ failure assessment (SOFA) score to 
bacteremic ICU patients. Infection, 2007;35:240-4. 
[18] Povoa P, Teixeira-Pinto AM, Carneiro AH. C-
reactive protein, an early marker of community-acquired 
sepsis resolution: a multi-center prospective 10 
observational study. Crit Care, 2011;15:R169. 
[19] Coelho LM, Salluh JI, Soares M, Bozza F, Verdeal 
JC, Castro-Faria-Neto HC, et al. Patterns of C-reactive 
protein ratio response in severe community-acquired 
pneumonia: a cohort study. Crit Care, 2012;16:R53. 15 
[20] Horan TC, Andrus M, Dudeck MA. CDC/NHSN 
surveillance definition of health care-associated infection 
and criteria for specific types of infections in the acute 
care setting. American journal of infection control, 
2008;36:309-32. 20 
[21] Jones AE, Focht A, Horton JM, Kline JA. 
Prospective external validation of the clinical 
effectiveness of an emergency department-based early 
goal-directed therapy protocol for severe sepsis and 
septic shock. Chest, 2007;132:425-32. 25 
23 
 
 
 
 
[22] Sebat F, Musthafa AA, Johnson D, Kramer AA, 
Shoffner D, Eliason M, et al. Effect of a rapid response 
system for patients in shock on time to treatment and 
mortality during 5 years. Critical care medicine, 
2007;35:2568-75. 5 
[23] Barochia AV, Cui X, Vitberg D, Suffredini AF, 
O'Grady NP, Banks SM, et al. Bundled care for septic 
shock: an analysis of clinical trials. Critical care medicine, 
2010;38:668-78. 
[24] Carlbom DJ, Rubenfeld GD. Barriers to 10 
implementing protocol-based sepsis resuscitation in the 
emergency department--results of a national survey. 
Critical care medicine, 2007;35:2525-32. 
[25] Schmit X, Vincent JL. The time course of blood C-
reactive protein concentrations in relation to the response 15 
to initial antimicrobial therapy in patients with sepsis. 
Infection, 2008;36:213-9. 
24 
 
 
 
 
 
Table 1 – Demographics characteristics of population 
 n = 58 Appropriate 
ATB (n=45) 
Inappropriate 
ATB (n=13) 
p 
Age (mean) 62.05 60.10 66.08 0.347 
Gender  
Male 
Female 
 
36 (62.1%) 
22 (37.9%) 
 
25 (62.5%) 
25 (37.5%) 
 
6 (46.2%) 
7 (53.8%) 
0.345 
Co-morbidities 
Diabetes 
Heart Failure 
Renal disease 
Chronic lung disease 
Chronic liver failure 
Cerebro-vascular disease 
Other neurological disease 
Immune Deficiency  
Neoplasia 
 
10 (17.2%) 
8 (13.8%) 
10 (17.2%) 
11 (19.0%) 
4 (6.9%) 
7 (12.1%) 
5 (8.6%) 
9 (15.5%) 
8 (10.3%) 
 
8 (20.0%) 
5 (12.5%) 
7 (17.5%) 
5 (12.5%) 
3 (7.5%) 
4 (10.0%) 
4 (10.0%) 
5 (12.5%) 
3 (7.5%) 
 
2 (16.7%) 
1 (8.3%) 
3 (25.0%) 
4 (33.3%) 
0 (0%) 
3 (25%) 
1 (8.3%) 
3 (25.0%) 
3 (23.1%) 
 
1.00 
1.00 
0.679 
0.185 
1.00 
0.33 
1.00 
0.366 
0.156 
Reason for ICUa admission  
Medical non coronary 
Coronary 
Emergency surgery NT 
Emergency surgery trauma 
Trauma non-surgicaL 
 
39 (67.2%) 
2 (3.4%) 
6 (10.3%) 
4 (6.9%) 
7 (12.1%) 
 
28 (70.0%) 
0 (0%) 
3 (7.5%) 
3 (7.5%) 
6(15.0%) 
 
8 (61.5%) 
1 (7.7%) 
3 (23.1%) 
1 (7.7%) 
0 (0%) 
 
- 
- 
- 
- 
- 
Severe Sepsis 
Septic Shock  
(91.2%) 
(53.4%) 
36 (92.3%) 
20 (50.0%) 
13 (100%) 
8 (61.5%) 
0.564 
0.536 
SAPS II (mean) 51.53(StdDev. 16.66) 49.85 52.69 0.475 
ICU LOS (median) 16 (IQR 7-28) 16.00 17.00 0.641 
Hospital LOS (median) 38(IQR 16-67) 36.5 46.00 0.542 
25 
 
 
 
 
ICU Mortality  37.9 (%) 11 (27.5%) 8 (61.5%) 0.044
a
 
Hospital Mortality  53.4 (%) 17 (42.5%) 10 (76.9%) 0.054 
Resolution of infection  37 (63.8%) 29 (80.6%) 5 (38.5%) 0.011
 a
 
ICU: intensive care unit, SAPS: Simplified Acute Physiology Score, ATB: 
antibiotics, LOS: length of stay, Emergency surgery NT: emergency 
surgery non-trauma. 
a
 Statistical significant   
 
5 
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Table 2 – Bloodstream infection  provenance    
 
 n = 58 Appropriate 
 ATB (n=40) 
Innapropriate 
ATB (n =13) 
p 
Place of acquisition   
Community 
Nosocomial  
 
17 (29,4%) 
41 (70.7%) 
 
13 (32.5%) 
27 (67.5%) 
 
3 (23.1%) 
10 (76.9%) 
 
0.731 
0.731 
 ATB: antibiotic  
  
 
Table 3 – Microbiology and Focus of infection 
 Central Line Abdominal Respiratory Urinary Skin/soft tissue CNS Other Total 
Gram positives 
Count 
% within MO 
% within focus of infection 
 
8 
42.1% 
65.5% 
 
0 
0% 
0% 
 
1 
5.3% 
11.1% 
 
2 
10.5% 
25.0% 
 
1 
5.3% 
33.3% 
 
2 
10.5% 
100% 
 
5 
26.3% 
83.3% 
 
19 
100% 
36.5% 
Fungi  
Count 
% within MO 
% within focus of infection 
 
1 
25.0% 
7.7% 
 
3 
75% 
27.3% 
 
0 
0% 
0% 
 
0 
0% 
0% 
 
0 
0% 
0% 
 
0 
0% 
0% 
 
0 
0% 
0% 
 
4 
100% 
7.7% 
Gram negatives 
Count 
% within MO 
% within focus of infection 
 
4 
13.8% 
30.8% 
 
8 
27.6% 
72.7% 
 
8 
27.6% 
88.9% 
 
6 
20.7% 
75% 
 
2 
6.9% 
66.7% 
 
0 
0% 
0% 
 
1 
3.4% 
16.7% 
 
29 
100% 
55.8% 
Total
a
 
Count 
% within MO 
% within focus of infection 
 
13 
25.0% 
100% 
 
11 
21.2% 
100% 
 
9 
17.3% 
100% 
 
8 
15.4% 
100% 
 
3 
5.8% 
100% 
 
2 
3.8% 
100% 
 
6 
11.5% 
100% 
 
52 
100% 
100% 
a
n=52; MO: microorganism; CNS: Central Nervous System 
28 
 
 
 
 
Table 4 – SOFA score variation between day 0, 1 and 3  
 
 Appropriate ATB
a 
Improved  / Not improved 
Innapropriate ATBb 
Improved / Not improved 
p 
Cardiovascular SOFA  
Day 0 – 1 
Day 0 – 3 
 
7 (18.4%)  vs 31 (81.6%) 
8 (22.2%)  vs 28 (77.8%) 
 
1 (7.7%)  vs 12 (92.3%) 
1 (8.3%)  vs 11 (91.7%) 
 
0.662 
0.416 
Respiratory SOFA  
Day 0 – 1 
Day 0 – 3 
 
6 (17.6%)  vs 28 (82.4%) 
10 (32.3%)  vs 21 (67.7%) 
 
0 (0.0%)  vs 13 (100.0%) 
1(8.3%)  vs  11 (91.7%) 
 
0.167 
0.139 
Renal SOFA  
Day 0 – 1 
Day 0 – 3 
 
3 (8.6%) vs 32(91.4%) 
2 (5.9%) vs 32 (94.1%) 
 
1 (8.3%) vs 11 (91.7%) 
3 (27.3%) vs 8 (72.7%) 
 
1.00 
0.085 
Hepatic SOFA 
Day 0 – 1 
Day 0 – 3 
 
5 (15.6%) vs  27 (84.4%) 
4 (14.8%) vs 23 (85.2%) 
 
0 (0%) vs 12 (100%) 
1 (10.0%) vs 9 (90.0%) 
 
0.301 
1.00 
Hematologic SOFA 
Day 0 – 1 
Day 0 – 3 
 
2 (5.3%) vs 36 (94.7%) 
6 (16.2%) vs 31 (83.8%) 
 
2 (15.4%) vs 11 (84.6%) 
1 (8.3%) vs 11 (91.7%) 
 
0.266 
0.665 
SOFA: Sepsis-related Organ Failure Assessment. 
an=40,bn=13 
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Figure 1 
 
CRP variations in appropriate vs inappropriate therapy groups 
CRP: C-reactive protein, atb: antibiotics 
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